Delivery Order SPE2DR25D1103-SPE2DR26FD949
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency on August 14, 2025, with an ultimate completion date of September 5, 2025. The delivery order is for XDEMVY 0.25% Drop 10ML and utilizes firm fixed price pricing with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $115,054.02 by the Defense Logistics Agency's Medical Supply Chain on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,123.36 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. The contract represents a child delivery order under the company's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $731,676.74 from the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,327.26 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,185.65 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a child delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for XDEMVY 0.25% drop in 10ml format, valued at $1,223.59 with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order is non-competitive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,680.04 on November 10, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price, competitively awarded contract (No Set-Aside Used) is scheduled for ultimate completion on November 12, 2025, with performance taking place at the company's corporate office location in Conshohocken, PA. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,835.64 by the Defense Logistics Agency's Medical Supply Chain on November 1, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by November 3, 2025, and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as a...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD949Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,184.60 delivery order by the Defense Logistics Agency on November 18, 2025, for XDEMVY 0.25% drop in 10ml format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA's pharmaceutical supply chain, which delivers medications and medical supplies to support military healthcare programs globally. The company holds a comprehensive prime IDC that enables it to supply a broad range of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning to transition to next-generation Pharmaceutical Prime Vendor Global Program contracts that will involve multiple regional awards among select contractors, positioning AmerisourceBergen competitively within the federal medical procurement landscape.